Home › Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S
 

Keywords :   


Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S

2013-03-25 09:30:00| drugdiscoveryonline News Articles

Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced that it launched the 36 and 54 milligram (mg) dosage strengths of Methylphenidate HCl Extended-Release (ER) Tablets USP (CII), generic version of CONCERTA

Tags: us additional generic strengths

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11171
15.11 3FLYOVER
15.11 PSA8 - 1ed
15.11DMC RAVEN 18g
15.11LOVE or DEAD Blu-ray
15.11 HSGI SURE-GRIP PADDED BELT a-tacs au
15.11 BOUNTY HUNTER
15.11
More »